Paid Clinical Trials in Oklahoma

Oklahoma has 776 paid clinical trials enrolling now across cities including Oklahoma City, Tulsa and Edmond. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 21, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

710 clinical trials

↓ Download CSV

NORM-HF Pivotal Study

for Heart Failure

Sites in Tulsa +2 more locations

Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)

Sex: All·Age: 18+

Code: NCT07574593·Recruiting·Listed May 2026

Apply to this trial

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

for Berger Disease

Sites in Oklahoma City +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 2 - 18

Code: NCT07498335·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

xDot Access Management System Early Feasibility Study

for Vascular Closure Devices

Sites in Tulsa +2 more locations

Sponsor: xDot Medical, Inc

Sex: All·Age: 18 - 80

Code: NCT07464353·Recruiting·Listed Mar 2026

Apply to this trial

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

for Cancer

Sites in Oklahoma City +7 more locations

Sponsor: Elephas

Sex: All·Age: 18+

Code: NCT07327489·Recruiting·Listed Jan 2026

Apply to this trial

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women

for Depressive Symptoms

Sites in Oklahoma City +2 more locations

Sponsor: BTL Industries Ltd.

Sex: Female·Age: 22 - 60

Code: NCT07413692·Recruiting·Listed Feb 2026

Apply to this trial

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

for Type II Diabetes Mellitus

Sites in Oklahoma City +8 more locations

Sponsor: Sun Pharmaceutical Industries Limited

Sex: All·Age: 18+

Code: NCT07282743·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

for Pulmonary Hypertension

Sites in Tulsa +2 more locations

Sponsor: Pulnovo Medical, Inc.

Sex: All·Age: 18 - 85

Code: NCT07214376·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

for Palmoplantar Pustulosis

Drug: Bimekizumab

Sites in Oklahoma City +5 more locations

Sponsor: UCB Biopharma SRL

Sex: All·Age: 18+

Code: NCT07219420·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for Gynecologic Cancers

Sites in Oklahoma City +7 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT07024784·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).

for Healthy

Sites in Oklahoma City +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 12 - 30·Accepts healthy volunteers

Code: NCT06655324·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

for Ovarian Cancer Recurrent

Sites in Oklahoma City +7 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06843447·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

for Non Small Cell Lung Cancer

Sites in Oklahoma City +4 more locations

Sponsor: Phanes Therapeutics

Sex: All·Age: 18+

Code: NCT05431270·Phase 1, Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Oklahoma City +7 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06004245·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for Ovarian Cancer

Drug: IMNN-001

Sites in Oklahoma City +1 more location

Sponsor: Imunon

Sex: Female·Age: 18+

Code: NCT05739981·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

A Study of DM002 in Patients With Advanced Solid Tumors

for Ovarian Neoplasms

Sites in Oklahoma City +1 more location

Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT06751329·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for Ovarian Cancer

Sites in Oklahoma City +6 more locations

Sponsor: Tubulis GmbH

Sex: All·Age: 18+

Code: NCT06303505·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

for Solid Tumor Malignancies

Sites in Oklahoma City +5 more locations

Sponsor: A2A Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT06136884·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

for Multiple Sclerosis

Sites in Oklahoma City +5 more locations

Sponsor: ModernaTX, Inc.

Sex: All·Age: 18 - 55

Code: NCT06735248·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Travoprost Intraocular Implant + iStent Infinite

for Glaucoma, Open-Angle

1 location in Oklahoma City

Sponsor: Glaukos Corporation

Sex: All·Age: 18+

Code: NCT06066645·Phase 4·Recruiting·Listed Oct 2023

Apply to this trial

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

for Acquired Antithrombin Deficiency

Sites in Oklahoma City +8 more locations

Sponsor: Octapharma

Sex: All·Age: 18 - 85

Code: NCT06096116·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

Combination of TATE and PD-1 Inhibitor in Liver Cancer

for Hepatocellular Carcinoma

Sites in Oklahoma City +2 more locations

Sponsor: Teclison Ltd.

Sex: All·Age: 18 - 80

Code: NCT03259867·Phase 2·Recruiting·Listed Aug 2017

Apply to this trial

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

for Heart Failure With Preserved Ejection Fraction

Sites in Oklahoma City +7 more locations

Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Sex: All·Age: 18+

Code: NCT05839730·Recruiting·Listed May 2023

Apply to this trial

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)

for Necrotizing Enterocolitis

Sites in Oklahoma City +7 more locations

Sponsor: Noveome Biotherapeutics, formerly Stemnion

Sex: All·Age: 2 Weeks - 8 Weeks

Code: NCT06315738·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC

for Diabetic Foot Ulcer

Sites in Tulsa +1 more location

Sponsor: Surgenex

Sex: All·Age: 18+

Code: NCT06515093·Recruiting·Listed Jul 2024

Apply to this trial

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

for Systemic Lupus Erythematosus (SLE)

Drug: Deucravacitinib

Sites in Oklahoma City +1 more location

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 75

Code: NCT06875960·Phase 4·Recruiting·Listed Mar 2025

Apply to this trial

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

for Glaucoma

Sites in Oklahoma City +2 more locations

Sponsor: Glaukos Corporation

Sex: All·Age: 18+

Code: NCT07075718·Phase 2, Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial

for Left Ventricle Remodeling

Sites in Oklahoma City +5 more locations

Sponsor: BioVentrix

Sex: All·Age: 18+

Code: NCT06813820·Recruiting·Listed Feb 2025

Apply to this trial

Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

for Diabetic Foot Ulcer (DFU)

Sites in Tulsa +7 more locations

Sponsor: Royal Biologics

Sex: All·Age: 18+

Code: NCT07209475·Phase 4·Recruiting·Listed Oct 2025

Apply to this trial

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

for Diabetic Foot Ulcer (DFU)

Sites in Tulsa +4 more locations

Sponsor: StimLabs

Sex: All·Age: 18+

Code: NCT06449638·Recruiting·Listed Jun 2024

Apply to this trial

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for Endometrial Cancer

Sites in Oklahoma City +8 more locations

Sponsor: Aadi Bioscience, Inc.

Sex: All·Age: 18+

Code: NCT05997017·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

for Postoperative Pain

Sites in Oklahoma City +4 more locations

Sponsor: Pacira Pharmaceuticals, Inc

Sex: All·Age: 0 - 6

Code: NCT06271265·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

for Relapsed/Refractory B-cell Malignancies

Sites in Canton +2 more locations

Sponsor: Ubix Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06590961·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Clinical Pre-screening Protocol for Ovarian Cancer

for Ovarian Cancer

Sites in Oklahoma City +1 more location

Sponsor: Allarity Therapeutics

Sex: Female·Age: 18+

Code: NCT03877796·Recruiting·Listed Mar 2019

Apply to this trial

Investigation of DEXA-C Anterior Cervical Interbody System

for Degenerative Disc Disease

Sites in Oklahoma City +3 more locations

Sponsor: Aurora Spine and Pain

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05883436·Recruiting·Listed Jun 2023

Apply to this trial

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

for Advanced Ovarian Cancer

Sites in Oklahoma City +1 more location

Sponsor: Allarity Therapeutics

Sex: Female·Age: 18+

Code: NCT03878849·Phase 2·Recruiting·Listed Mar 2019

Apply to this trial

Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)

for Hip Arthroplasty, Total

1 location in Tulsa

Sponsor: Exactech

Sex: All·Age: 18+

Code: NCT05849961·Recruiting·Listed May 2023

Apply to this trial

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

for HPV-Related Cervical Carcinoma

Sites in Tulsa +3 more locations

Sponsor: Theravectys S.A.

Sex: All·Age: 18+

Code: NCT06319963·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo

for Head Lice

1 location in Enid

Sponsor: Oystershell NV

Sex: All·Age: 6 Months+

Code: NCT07191457·Recruiting·Listed Sep 2025

Apply to this trial

BostonGene and Exigent Genomic INsight Study

for Breast Cancer

Sites in Tulsa +6 more locations

Sponsor: BostonGene

Sex: All·Age: 18+

Code: NCT06272864·Recruiting·Listed Feb 2024

Apply to this trial

IV Ensure in Patients Receiving OPAT

for Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates

1 location in Oklahoma City

Sponsor: IV Ensure

Sex: All·Age: 18+

Code: NCT06623318·Recruiting·Listed Oct 2024

Apply to this trial